GlassScriptPhysician profile
Robert S Winfield
NPI 1881658318
$1,333.34
in general payments reported to CMS, 2019-2025
13 companies · $477 in 2025
The $477 reported for 2025 was more than what 78% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $12.35 · 2021: $85.61 · 2022: $309 · 2023: $45.38 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $317.76 | 2020-2025 | Proclaim, Eterna |
| Medtronic, INC. | $289.23 | 2022 | |
| Saluda Medical Americas, INC. | $150.68 | 2025 | Evoke |
| Spr Therapeutics, INC | $146.98 | 2025 | Sprint Pns System |
| Nevro Corp. | $131.78 | 2019 | |
| Amgen INC. | $125.00 | 2019 | |
| Stimwave Technologies Incorporated | $74.64 | 2019 | |
| Stryker Corporation | $25.02 | 2025 | Optablate |
| Acell, INC. | $19.40 | 2019 | |
| Avanos Medical | $15.43 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.28 | 2019 | |
| Pfizer INC. | $11.55 | 2019 | |
| Electronic Waveform Lab, INC. | $10.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Winfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.